These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 33251906

  • 1. Hemodynamic Response to Vasopressin Dosage of 0.03 Units/Min vs. 0.04 Units/Min in Patients With Septic Shock.
    Bauer SR, Sacha GL, Lam SW, Wang L, Reddy AJ, Duggal A, Vachharajani V.
    J Intensive Care Med; 2022 Jan; 37(1):92-99. PubMed ID: 33251906
    [Abstract] [Full Text] [Related]

  • 2. Hypotension Risk Based on Vasoactive Agent Discontinuation Order in Patients in the Recovery Phase of Septic Shock.
    Sacha GL, Lam SW, Duggal A, Torbic H, Reddy AJ, Bauer SR.
    Pharmacotherapy; 2018 Mar; 38(3):319-326. PubMed ID: 29328496
    [Abstract] [Full Text] [Related]

  • 3. Influence of Timing and Catecholamine Requirements on Vasopressin Responsiveness in Critically ill Patients with Septic Shock.
    Jakowenko ND, Murata J, Kopp BJ, Erstad BL.
    J Intensive Care Med; 2022 Nov; 37(11):1512-1519. PubMed ID: 35195486
    [Abstract] [Full Text] [Related]

  • 4. Concomitant vasopressin and hydrocortisone therapy on short-term hemodynamic effects and vasopressor requirements in refractory septic shock.
    Buckley MS, MacLaren R.
    J Crit Care; 2017 Dec; 42():6-11. PubMed ID: 28647651
    [Abstract] [Full Text] [Related]

  • 5. Effect of early vasopressin combined with norepinephrine on short-term mortality in septic shock: A retrospective study based on the MIMIC-IV database.
    He D, Zhang L, Hu H, Gu WJ, Lu X, Qiu M, Li C, Yin H, Lyu J.
    Am J Emerg Med; 2023 Jul; 69():188-194. PubMed ID: 37167890
    [Abstract] [Full Text] [Related]

  • 6. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis.
    Dünser MW, Mayr AJ, Ulmer H, Ritsch N, Knotzer H, Pajk W, Luckner G, Mutz NJ, Hasibeder WR.
    Anesth Analg; 2001 Jul; 93(1):7-13. PubMed ID: 11429329
    [Abstract] [Full Text] [Related]

  • 7. Effect of Body Weight on Hemodynamic Response in Patients Receiving Fixed-Dose Vasopressin for Septic Shock.
    Hodge EK, Hughes DW, Attridge RL.
    Ann Pharmacother; 2016 Oct; 50(10):816-23. PubMed ID: 27340145
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and Outcomes After Vasopressin Guideline Implementation in Septic Shock.
    Wu JY, Stollings JL, Wheeler AP, Semler MW, Rice TW.
    Ann Pharmacother; 2017 Jan; 51(1):13-20. PubMed ID: 27630192
    [Abstract] [Full Text] [Related]

  • 9. Hemodynamic Instability Secondary to Vasopressin Withdrawal in Septic Shock.
    Bissell BD, Magee C, Moran P, Bastin MLT, Flannery AH.
    J Intensive Care Med; 2019 Sep; 34(9):761-765. PubMed ID: 28750598
    [Abstract] [Full Text] [Related]

  • 10. Effect of Vasopressin Dose on Hemodynamic Response in Obese Patients With Septic Shock: A Retrospective Observational Study.
    Dubrawka CA, Betthauser KD, Pope HE, Gibson GA.
    Ann Pharmacother; 2021 Dec; 55(12):1447-1454. PubMed ID: 33813908
    [Abstract] [Full Text] [Related]

  • 11. Effects of continuous vasopressin infusion in patients with septic shock.
    Obritsch MD, Jung R, Fish DN, MacLaren R.
    Ann Pharmacother; 2004 Dec; 38(7-8):1117-22. PubMed ID: 15178740
    [Abstract] [Full Text] [Related]

  • 12. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
    Hall LG, Oyen LJ, Taner CB, Cullinane DC, Baird TK, Cha SS, Sawyer MD.
    Pharmacotherapy; 2004 Aug; 24(8):1002-12. PubMed ID: 15338849
    [Abstract] [Full Text] [Related]

  • 13. A Selective V(1A) Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock.
    He X, Su F, Taccone FS, Laporte R, Kjølbye AL, Zhang J, Xie K, Moussa MD, Reinheimer TM, Vincent JL.
    Crit Care Med; 2016 Jan; 44(1):23-31. PubMed ID: 26496451
    [Abstract] [Full Text] [Related]

  • 14. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial.
    Lauzier F, Lévy B, Lamarre P, Lesur O.
    Intensive Care Med; 2006 Nov; 32(11):1782-9. PubMed ID: 17019548
    [Abstract] [Full Text] [Related]

  • 15. Vasopressin Plasma Concentrations Are Not Associated with Hemodynamic Response to Exogenous Vasopressin for Septic Shock.
    Yerke JR, Sacha GL, Scheraga RG, Culver DA, Abraham S, Torbic H, Lam SW, Ammar MA, Olman MA, Bauer SR.
    Pharmacotherapy; 2020 Jan; 40(1):33-39. PubMed ID: 31705703
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.
    Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Cecchini V, Bachetoni A, D'Alessandro M, Van Aken H, Pietropaoli P, Westphal M.
    Crit Care; 2009 Jan; 13(4):R130. PubMed ID: 19664253
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Timing of vasopressin initiation and mortality in patients with septic shock: analysis of the MIMIC-III and MIMIC-IV databases.
    Xu J, Cai H, Zheng X.
    BMC Infect Dis; 2023 Apr 03; 23(1):199. PubMed ID: 37013474
    [Abstract] [Full Text] [Related]

  • 20. Discontinuation of vasopressin before norepinephrine increases the incidence of hypotension in patients recovering from septic shock: a retrospective cohort study.
    Bauer SR, Aloi JJ, Ahrens CL, Yeh JY, Culver DA, Reddy AJ.
    J Crit Care; 2010 Jun 03; 25(2):362.e7-362.e11. PubMed ID: 19926252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.